KRISTEN ROSE: Open Payments
NPI 1124446414 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 16 payments from 11 companies in 2025. Trend: 2023 $1,378 · 2024 $515 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $149 |
| Genmab U.S., Inc. | 1 | $121 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| ABBVIE INC. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: Epkinly, RYBREVANT, LIBTAYO, TECVAYLI, DARZALEX, SCEMBLIX, ELAHERE, KEYTRUDA.
Industry payments across MD — which companies pay providers there.
